IRIS
BUONERBA, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.245
EU - Europa 643
AS - Asia 463
AF - Africa 41
OC - Oceania 2
SA - Sud America 1
Totale 2.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.225
IT - Italia 256
SG - Singapore 235
CN - Cina 122
NL - Olanda 112
VN - Vietnam 56
GB - Regno Unito 47
DE - Germania 45
UA - Ucraina 45
CI - Costa d'Avorio 39
FI - Finlandia 39
IN - India 37
IE - Irlanda 36
SE - Svezia 31
CA - Canada 20
RU - Federazione Russa 9
BE - Belgio 5
FR - Francia 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
HK - Hong Kong 4
IR - Iran 3
AT - Austria 2
MA - Marocco 2
AU - Australia 1
BN - Brunei Darussalam 1
CH - Svizzera 1
EC - Ecuador 1
HR - Croazia 1
JP - Giappone 1
KZ - Kazakistan 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
TR - Turchia 1
Totale 2.395
Salva come PNG Salva come JPEG
Città #
Chandler 207
Singapore 202
Amsterdam 111
Naples 97
Ashburn 94
Santa Clara 89
Millbury 59
Dong Ket 56
Beijing 39
Lawrence 38
Boston 36
Napoli 34
Des Moines 33
Princeton 27
Nanjing 22
Wilmington 21
Washington 16
Ottawa 15
Helsinki 14
Seattle 13
Dallas 11
Dublin 10
Fairfield 8
Hebei 8
Nanchang 8
Milan 7
Caserta 6
Jacksonville 6
Los Angeles 6
Norwalk 6
Redwood City 6
Shenyang 6
Boardman 5
Changsha 5
Woodbridge 5
Brno 4
Courcelles 4
Dearborn 4
Hong Kong 4
Houston 4
Kronberg 4
Moscow 4
Munich 4
Shanghai 4
Tianjin 4
Toronto 4
Abidjan 3
Ann Arbor 3
Ardabil 3
Augusta 3
Aversa 3
Catania 3
Falls Church 3
New York 3
Pune 3
Rome 3
Dalmine 2
Falkenstein 2
Kochi 2
Kunming 2
Latina 2
Locate di Triulzi 2
Monmouth Junction 2
Nuremberg 2
Pescara 2
Piana 2
Pontedera 2
Rovereto 2
Saint-Fons 2
Salerno 2
Shenzhen 2
Tronzano Vercellese 2
Vienna 2
Zhengzhou 2
Acerra 1
Agadir 1
Alba 1
Auckland 1
Bandar Seri Begawan 1
Brussels 1
Casablanca 1
Changzhou 1
Chicago 1
Cinisello Balsamo 1
Clifton 1
Cormeilles-en-Parisis 1
Crispano 1
Darmstadt 1
Dongguan 1
Edinburgh 1
Ercolano 1
Florence 1
Frankfurt am Main 1
Friesland 1
Ghedi 1
Gunzenhausen 1
Hangzhou 1
Hanover 1
Hefei 1
Indiana 1
Totale 1.462
Salva come PNG Salva come JPEG
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 145
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 58
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 57
A comprehensive outlook on inracerebral therapy of malignant gliomas 55
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 55
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 51
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 51
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 48
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 48
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 47
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 45
Biomarkers in localized prostate cancer 44
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 44
Castration-resistant prostate cancer: current and emerging treatment strategies 43
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 43
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 43
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 43
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. 42
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 41
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 41
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 40
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 40
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 40
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 39
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 38
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 37
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 37
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 37
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 36
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 36
Locally advanced paranasal sinus carcinoma: A study of 30 patients 36
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 36
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review 36
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 35
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 34
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 34
The emerging role of obesity, diet and lipid metabolism in prostate cancer 33
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 33
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 33
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 33
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 33
Imatinib mesylate in thymic epithelial malignancies. 32
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study 32
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 30
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 30
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 30
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 30
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 30
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy 30
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 29
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 29
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 29
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 28
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 28
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 28
COVID-19 and prostate cancer: A complex scenario with multiple facets 27
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 27
Liquid biopsy in bladder cancer: State of the art and future perspectives 24
Urologic malignancies: advances in the analysis and interpretation of clinical findings 23
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 22
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting 22
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 20
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 19
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 17
Fascin-1 and its role as a serological marker in prostate cancer: A prospective case-control study 16
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 15
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 14
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 14
Instant messaging in cancer care 12
null 8
Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer 8
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 8
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL 1
Totale 2.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 0 8 9 3 18 36 7
2020/2021192 7 2 10 6 14 22 10 1 14 11 23 72
2021/2022556 20 6 10 2 3 5 8 13 144 45 159 141
2022/2023611 66 25 33 15 73 62 8 63 100 112 46 8
2023/2024442 12 67 85 36 25 55 3 62 2 6 58 31
2024/2025454 101 94 3 32 106 109 9 0 0 0 0 0
Totale 2.512